Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Right versus left pulmonary artery anastomosis of the right ventricle-to-pulmonary artery conduit in Norwood procedure: Comparable outcomes with longer Glenn operative time.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Successful transcatheter closure of a congenital aorto-right ventricular fistula after Norwood procedure.

JTCVS techniques·2026
Same author

Increased Risk of Disabilities in Children and Adolescents With Congenital Heart Disease of Any Severity.

Journal of the American Heart Association·2026
Same author

A three generation family with VACTERL association is found to have a rare form of diamond-blackfan anaemia.

European journal of human genetics : EJHG·2026
Same author

Long-Term Outcomes of the Norwood Operation: Why We Are Surprised But Should Not Be.

Journal of the American College of Cardiology·2026
Same author

Correction to: Neurocognitive Dysfunction and Smaller Brain Volumes in Adolescents and Adults With a Fontan Circulation.

Circulation·2026

Related Experiment Video

Updated: Mar 16, 2026

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol
12:21

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Published on: July 25, 2016

11.2K

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small

Hananeh Fonoudi1, Hassan Ansari2, Saeed Abbasalizadeh3

  • 1Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR; Developmental and Stem Cell Biology Division, Victor Chang Cardiac Research Institute; St. Vincent´s Clinical School, Faculty of Medicine, University of New South Wales; Department of Developmental Biology, University of Science and Culture, Tehran, Iran.

Journal of Visualized Experiments : Jove
|August 9, 2016
PubMed
Summary

This study presents a new method for producing human cardiomyocytes from pluripotent stem cells. The protocol uses signaling pathway manipulation for efficient large-scale cell generation, benefiting research and clinical applications.

More Related Videos

Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation
11:53

Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation

Published on: March 18, 2015

19.7K
Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

20.8K

Related Experiment Videos

Last Updated: Mar 16, 2026

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol
12:21

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Published on: July 25, 2016

11.2K
Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation
11:53

Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation

Published on: March 18, 2015

19.7K
Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

20.8K

Area of Science:

  • Stem cell biology
  • Cardiovascular research
  • Developmental biology

Background:

  • Human pluripotent stem cells (hPSCs) are crucial for disease modeling and therapeutic development.
  • Efficient large-scale production of functional cardiomyocytes from hPSCs is essential for these applications.

Purpose of the Study:

  • To develop a robust and efficient protocol for large-scale human cardiomyocyte differentiation from hPSCs.
  • To optimize differentiation using temporal manipulation of key signaling pathways.

Main Methods:

  • Temporal manipulation of WNT, TGF-β, and SHH signaling pathways.
  • Differentiation of single-cell passaged hPSC lines in static and stirred suspension bioreactors.
  • Protocol adaptation for hPSC lines not initially suited for single-cell passaging.

Main Results:

  • Achieved ~100% beating spheroids with >80% cardiac troponin T-positive cells within 15 days.
  • Validated the protocol across multiple hPSC lines, including 42 lines with the adapted protocol.
  • Generated cardiomyocytes exhibited expected lineage-specific markers and electrophysiological functions.

Conclusions:

  • The developed protocol offers a simple, efficient, and robust platform for scalable human cardiomyocyte production.
  • This method significantly advances the potential of hPSCs in research, disease modeling, and pharmaceutical/clinical applications.